Showing results (1391-1400 of 1,451) with videos related to
Sort By:
Pageof 146
Cancer Cell|June 21, 2024
Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trialQing Zhou, Yi Pan, Xuening Yang, et al.Ebiomedicine|November 24, 2022
Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaquesCharles W Dobard, M Melissa Peet, Kenji Nishiura, et al.In Vivo (Athens, Greece)|April 27, 2018
The Association of <i>Matrix Metalloproteinase-1</i> Promoter Polymorphisms with Breast CancerChieh-Lun Hsiao, Liang-Chih Liu, Tzu-Ching Shih, et al.Cancer Cell|July 12, 2017
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell LymphomaYing Gu, Jiawei Zhang, Xiaoxiao Ma, et al.The EMBO Journal|February 3, 2016
PAQR3 controls autophagy by integrating AMPK signaling to enhance ATG14L-associated PI3K activityDa-Qian Xu, Zheng Wang, Chen-Yao Wang, et al.Acta Pharmacologica Sinica|January 20, 2025
Identifying a non-conserved site for achieving allosteric covalent inhibition of CECR2Cai-Ling Tang, Yuan-Qing Li, Xi-Kun Du, et al.Virus Evolution|March 21, 2024
High HIV diversity, recombination, and superinfection revealed in a large outbreak among persons who inject drugs in Kentucky and Ohio, USAWilliam M Switzer, Anupama Shankar, Hongwei Jia, et al.Signal Transduction and Targeted Therapy|June 16, 2026
Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trialYi Pan, Xuening Yang, Qing Zhou, et al.Journal of Hematology & Oncology|December 7, 2025
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapyYi-Long Wu, Lin Wu, Nan Bi, et al.Pageof 146